zidovudine has been researched along with Malignant Melanoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferko, B; Humer, J; Muster, T; Pehamberger, H; Rapberger, R; Waltenberger, A | 1 |
| Ferreira, LM; Gragnani, A; Lipay, MV; Oliveira, AF; Santos, ID; Souza Sobrinho, CP | 1 |
| Kamińska, B; Lasek, W; Orzeszko, A; Stoksik, M; Switaj, T | 1 |
| Chandrasekaran, B; Duch, DS; Kute, TE | 1 |
| Furlong, C; Multani, AS; Pathak, S | 1 |
| Breton, P; Chermann, JC; George, MD; Klein, JL; Kurtzberg, J; Olden, K; Roberts, JD | 1 |
6 other study(ies) available for zidovudine and Malignant Melanoma
| Article | Year |
|---|---|
Azidothymidine inhibits melanoma cell growth in vitro and in vivo.
Topics: Animals; Anti-HIV Agents; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Synergism; Humans; Melanoma; Mice; Mice, SCID; Neoplasm Transplantation; Random Allocation; S Phase; Skin Neoplasms; Zidovudine | 2008 |
AZT on telomerase activity and cell proliferation in HS 839.T melanoma cells.
Topics: Adult; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Humans; Melanoma; Skin Neoplasms; Telomerase; Time Factors; Zidovudine | 2012 |
Tumor necrosis factor-alpha production-regulating activity of phthalimide derivatives in genetically modified murine melanoma cells B78H1.
Topics: Animals; Drug Design; Melanoma; Mice; Phthalimides; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Zidovudine | 2003 |
Synchronization of cells in the S phase of the cell cycle by 3'-azido-3'-deoxythymidine: implications for cell cytotoxicity.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Division; Cell Survival; Colonic Neoplasms; Computer Simulation; DNA, Neoplasm; Drug Synergism; Flow Cytometry; Fluorouracil; Humans; Leukemia; Melanoma; Methotrexate; Pancreatic Neoplasms; S Phase; Tumor Cells, Cultured; Zidovudine | 1995 |
Reduction of telomeric signals in murine melanoma and human breast cancer cell lines treated with 3'-azido-2'-3'-dideoxythymidine.
Topics: Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; DNA, Neoplasm; Enzyme Inhibitors; Humans; In Situ Hybridization, Fluorescence; Interphase; Melanoma; Metaphase; Mice; Telomerase; Telomere; Tumor Cells, Cultured; Zidovudine | 1998 |
Swainsonine protects both murine and human haematopoietic systems from chemotherapeutic toxicity.
Topics: Adjuvants, Immunologic; Animals; Antimetabolites; Antineoplastic Agents; Bone Marrow Cells; Cyclophosphamide; Drug Interactions; Female; Hematopoietic Stem Cells; Humans; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Swainsonine; Tumor Cells, Cultured; Zidovudine | 1999 |